The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC | MicrobiomeTrials← Back to trialsNCT07507513
The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-03-28Est. Completion: 2029-02-28
Enrollment target: 288 participants Locations- The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Other microbiome trials you might be interested in
Ulcerative Colitis (UC)Fecal CalprotetinFIT
This multicenter prospective cohort aims to evaluate whether combined changes in fecal calprotectin (FC) and fecal immun…
Jinan, ChinaEst. completion Aug 1, 2026
Ulcerative ColitisInflammatory Bowel DiseasesColitisColitis, Ulcerative
This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active…
Canoga Park, United StatesEst. completion Jun 2027